Introduction
There has been a dramatic increase in the incidence of diabetes in human societies during the past decade. It's prevalence has particularly raised faster in the low-and middle-income countries than in the highincome countries. Diabetes is an important public health problem and the number of the cases along with the prevalence of diabetes has been steadily increasing over the past few decades [1] . The total number of people with diabetes is predicated to rise from 171 million in 2000 to 366 million in 2030 [2] . Type 2 diabetes is the commonest form of diabetes constituting around 90% of the total this population whereas type 1 diabetes constitutes about 10-15% of the diabetic population.
Ethnicity, age, life style, and genetic factors play a major role in the variation of incidence of all types of diabetes [3] . While diabetes is classically divided as type 1 and type 2 diabetes, there are some forms of diabetes which cannot be classified into either of these categories. The subgroup of patients diagnosed with type 2 diabetes bears circulating antibodies to islet cell autoantibodies and more frequently to glutamic acid decarboxylase (GADA) thus distinguishing them from type 2 diabetes [4, 5] . This condition is accompanied by the onset of diabetes after 35 years of age [6] [7] [8] and not requiring insulin, during at least the first 6 months after diagnosis thus distinguishes these patients from classic type 1 diabetes [6, 9] . This subset is named latent autoimmune diabetes in adults (LADA) [9, 10] or slowly progressive insulin-dependent diabetes mellitus [11, 12] . Epidemiological studies suggest that LADA may account for 2-12% of all the cases of diabetes [6] . There are numerous reports about the prevalence and characteristic of LADA in the world [3, 7, 8, 13] . Since LADA is often misdiagnosed as type 2 diabetes, it must be properly recognized and managed appropriately at the clinical level. Little is known concerning the prevalence and significance of islet cell autoimmunity in the elderly patients affected with type 2 diabetes in the Middle East. In Iran, there are few reports on the prevalence of LADA [14] [15] [16] [17] . In this cross-sectional study, we were looking for investigating the prevalence of LADA and the relationship between occurrence of it and some parameters such as age, gender, family history of diabetes, body mass index (BMI), blood pressure, serum cholesterol and C peptide level in
Torbat-e Heydarieh, Razavi Khorasan province, Iran. 2) lack of requirement for insulin at least 6 months after the diagnosis of type 2 diabetes; and 3) serum GADA positivity as tested by enzyme-linked immunosorbent assay (ELISA).
Materials and Methods

Subjects
Data colection
Data on age, gender, age at diagnosis, health status, treatment and family history of diabetes, were collected from participants at the screening phase by using a questionnaire.
Family history of diabetes was defined as having diabetes in any of the following family members: parents, grandparents (either paternal or maternal), and siblings. Blood pressure was measured by a trained physician using a mercury sphygmomanometer using a standardized protocol [19] . Hypertension was defined as systolic blood pressure (SBP) ≥140 mm Hg or diastolic blood pressure (DBP) ≥90 mm Hg.
Laboratory measurements
The peripheral blood (10 mL) was drawn from each subject following overnight 8 h fasting. CO. Iran). C-peptide was determined using commercial ELISA kits (IBL, USA). Intra and inter assay coefficients of variation were less than 10% and the analytical sensitivity was 0.064 ng/mL. C-peptide concentrations were determined using a standard curve derived from known amounts of standard absorbance readings at 450 nm. GAD antibodies were determined in the above-mentioned groups using Isletest GAD diagnostic kit (Diametra Co., Italy cat: DKO-082) with 92.3% sensitivity and 98.6% specificity.
Statistical Analysis
All statistical analyses were performed using 
Discussion
The main objective of this study was to determine the prevalence and characteristics of LADA in type 2 diabetic patients in Torbate Heydarieh, Iran. In this study the prevalence rate of LADA was 11.2%. According to our findings, gender had no important role in the development of this disease. Whereas
China study indicated that female gender is a risk factor of LADA [3] , in India, the survey mentioned that the prevalence of LADA significantly higher in males than in females [13] . Comparison of age range in the autoantibody positive group showed a tendency toward the lower age range compared to autoantibody negative subjects.
On the other hand, mean age of GADA positive patients was significantly lower than GADA negative subjects which is agreement with studies performed in India, Korea and Europe [13, 20, 21] . Our study showed no significant difference in family history of diabetes, BMI values and hypertension between LADA and non LADA subjects.
However, our findings indicate that family history of diabetes is an important risk factor in the incidence of both types of diabetes. This finding is consonant with the result obtained from Kerman study in 2015 [16] and Japan in 2002 [22] while studies in China show that family history of diabetes may be associated with the occurrence of LADA [3] . Our data in the case of BMI value is contrary to the information obtained from recent studies [3, 7, 13, 23] . In these studies, LADA patients had a respectively, while in Kerman (a province of Iran), it has been reported as 14.2% [16] .
Differences in the prevalence of LADA worldwide may be relevant to age at diagnosis, criteria of diagnosis, disease duration at study, and the numbers of patients under the study [29] . However the limitation of this study is the relatively small number of patients 
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